PubMed

Optimal clinical trial designs for immune-based therapies in persistent viral infections.

Smith KA.

Med Immunol. 2002 Nov 21;1(1):4.PMID: 12459051 [PubMed - as supplied by publisher]Related articlesFree article

Mismatched double-stranded RNA: polyI:polyC12U.

[No authors listed]

Drugs R D. 2004;5(5):297-304.PMID: 15357629 [PubMed - indexed for MEDLINE]Related articles

Lopinavir/ritonavir: a review of its use in the management of HIV infection.

Cvetkovic RS, Goa KL.

Drugs. 2003;63(8):769-802. Review.PMID: 12662125 [PubMed - indexed for MEDLINE]Related articles

Antiviral strategies.

Müller B, Kräusslich HG.

Handb Exp Pharmacol. 2009;(189):1-24. Review.PMID: 19048195 [PubMed - indexed for MEDLINE]Related articles

Recent advances in the development of HIV-1 Tat-based vaccines.

Caputo A, Gavioli R, Ensoli B.

Curr HIV Res. 2004 Oct;2(4):357-76. Review.PMID: 15544457 [PubMed - indexed for MEDLINE]Related articles

Molecular biological assessment methods and understanding the course of the HIV infection.

Katzenstein TL.

APMIS Suppl. 2003;(114):1-37. Review.PMID: 14626050 [PubMed - indexed for MEDLINE]Related articles

Initiation of antiretroviral therapy during chronic SIV infection leads to rapid reduction in viral loads and the level of T-cell immune response.

Boyer JD, Kumar S, Robinson T, Parkinson R, Wu L, Lewis M, Weiner DB.

J Med Primatol. 2006 Aug;35(4-5):202-9. Erratum in: J Med Primatol. 2007 Feb;36(1):55. Watkins, David I [removed]. PMID: 16872283 [PubMed - indexed for MEDLINE]Related articles

Recent progress in the development of inhibitors of human immunodeficiency virus (hiv) integrase for the management of hiv infection.

Lin SS, Xu F, Liao PH, Yang CC.

Acta Virol. 2008;52(4):197-207.PMID: 19143475 [PubMed - in process]Related articles

Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection.

Rutherford GW, Sangani PR, Kennedy GE.

Cochrane Database Syst Rev. 2003;(4):CD002037. Review.PMID: 14583945 [PubMed - indexed for MEDLINE]Related articles

Boosting immunity by antiviral drug therapy: a simple relationship among timing, efficacy, and success.

Komarova NL, Barnes E, Klenerman P, Wodarz D.

Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1855-60. Epub 2003 Feb 6.PMID: 12574516 [PubMed - indexed for MEDLINE]Related articlesFree article

Cross-study analysis of the relative efficacies of oral antiviral therapies for chronic hepatitis B infection in nucleoside-naive patients.

Dienstag JL, Wei LJ, Xu D, Kreter B.

Clin Drug Investig. 2007;27(1):35-49. Review.PMID: 17177578 [PubMed - indexed for MEDLINE]Related articles

Hepatitis B and C virus infections in the immune compromised.

Haydon GH, Mutimer DJ.

Curr Opin Infect Dis. 2003 Oct;16(5):473-9. Review.PMID: 14502001 [PubMed - indexed for MEDLINE]Related articles

Combining antiretroviral drugs and immune therapies: an approach to achieve clinical benefit after treatment interruption.

Lisziewicz J.

Curr Opin HIV AIDS. 2008 Mar;3(2):104-11.PMID: 19372950 [PubMed - in process]Related articles

Two-year clinical and immune outcomes in human immunodeficiency virus-infected children who reconstitute CD4 T cells without control of viral replication after combination antiretroviral therapy.

Ghaffari G, Passalacqua DJ, Caicedo JL, Goodenow MM, Sleasman JW.

Pediatrics. 2004 Nov;114(5):e604-11. Epub 2004 Oct 18.PMID: 15492356 [PubMed - indexed for MEDLINE]Related articlesFree article

Predictors of plasma human immunodeficiency virus type 1 RNA control after discontinuation of highly active antiretroviral therapy initiated at acute infection combined with structured treatment interruptions and immune-based therapies.

Lafeuillade A, Poggi C, Hittinger G, Counillon E, Emilie D.

J Infect Dis. 2003 Nov 15;188(10):1426-32. Epub 2003 Oct 27.PMID: 14624367 [PubMed - indexed for MEDLINE]Related articles

Treatment interruptions in HIV-infected subjects.

Bongiovanni M, Casana M, Tincati C, d'Arminio Monforte A.

J Antimicrob Chemother. 2006 Sep;58(3):502-5. Epub 2006 Jul 1.PMID: 16816398 [PubMed - indexed for MEDLINE]Related articlesFree article

CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - a review, hypothesis and implications.

Becker Y.

Virus Genes. 2005 Mar;30(2):251-66. Review.PMID: 15744581 [PubMed - indexed for MEDLINE]Related articles

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.PMID: 17472413 [PubMed - indexed for MEDLINE]Related articles

[Advances in antiviral chemotherapy]

Baba M.

Uirusu. 2005 Jun;55(1):69-75. Review. Japanese. PMID: 16308532 [PubMed - indexed for MEDLINE]Related articlesFree article

Antiviral drugs in influenza: an adjunct to vaccination in some situations.

[No authors listed]

Prescrire Int. 2006 Feb;15(81):21-30.PMID: 16548114 [PubMed - indexed for MEDLINE]Related articles